# Study of Panobinostat Monotherapy in Women With HER2-negative Locally Recurrent or Metastatic Breast Cancer

> **NCT00777049** · PHASE2 · COMPLETED · sponsor: **Translational Research in Oncology** · enrollment: 54 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Panobinostat

## Key facts

- **NCT ID:** NCT00777049
- **Lead sponsor:** Translational Research in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2016-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00777049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00777049, "Study of Panobinostat Monotherapy in Women With HER2-negative Locally Recurrent or Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00777049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*